AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
Feb 27 14:16 ET
AbCellera Biologics | 8-K: Current report
Feb 23 16:56 ET
AbCellera Biologics | 10-K: Annual report
Feb 20 22:18 ET
AbCellera Biologics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 20 16:54 ET
AbCellera Biologics | 8-K: Current report
Feb 20 16:33 ET
AbCellera Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(7.9%),Baker Bros. Advisors (GP) LLC(7.9%), etc.
Feb 14 17:49 ET
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Carl L.G. Hansen(20.6%),Thermopylae Holdings Ltd.(19.2%)
Feb 13 18:14 ET
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(8.29%)
Jan 29 11:48 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Lecault Veronique
Jan 16 00:00 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Stimart Tryn
Jan 16 00:00 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Booth Andrew
Jan 16 00:00 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
Jan 16 00:00 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-10% Owner Thermopylae Holdings Ltd.
Dec 19, 2023 18:08 ET
AbCellera Biologics | 8-K: Current report
Nov 28, 2023 17:28 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hansen Carl L. G.
Nov 27, 2023 16:45 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Montalbano John S.
Nov 8, 2023 15:29 ET
AbCellera Biologics | 10-Q: Q3 2023 Earnings Report
Nov 2, 2023 16:27 ET
AbCellera Biologics | 8-K: Current report
Nov 2, 2023 16:13 ET
AbCellera Biologics | 8-K: Current report
Oct 12, 2023 20:03 ET
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R
Sep 26, 2023 12:26 ET
No Data
No Data